Updated July 2026 · 9 min read

Heparin-Induced Thrombocytopenia: The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Heparin-induced thrombocytopenia is one of the great counterintuitive diagnoses in critical care. The platelet count drops — so your instinct says bleeding — but HIT is a clotting disorder. The very drug given to prevent clots has triggered an immune reaction that makes the blood dangerously prothrombotic. Recognizing HIT means overriding the reflex the low platelet count creates.

The paradox: low platelets, but clotting

In HIT, heparin binds a protein called platelet factor 4 (PF4), and the immune system makes antibodies against the heparin–PF4 complex. Those antibodies then activate platelets on a large scale. The activated platelets clump into clots (consuming themselves, which is why the count falls) and spew out procoagulant material. So the low platelet count is not a bleeding signal — it is the footprint of platelets being used up making clots. The dangerous outcomes of HIT are new thromboses: DVT, PE, limb artery occlusion, stroke, MI, and clotted lines and filters.

The timing is a clue by itself

HIT has a signature clock. In a patient with no recent heparin exposure, the platelet count typically falls 5 to 10 days after heparin is started. If the patient received heparin within the past roughly 100 days, pre-formed antibodies can cause a rapid-onset drop within hours of re-exposure. A fall that happens on day 1 with no prior exposure is unlikely to be HIT. Knowing when the heparin started — and when the count began to drop — is information the bedside nurse often owns before anyone else.

The 4Ts score

Because confirmatory antibody testing takes time, clinicians use the 4Ts score to estimate pretest probability and decide whether to act now. Each "T" scores 0, 1, or 2:

A low 4Ts score (0–3) makes HIT very unlikely and usually means you can keep looking elsewhere for the thrombocytopenia. An intermediate or high score triggers the HIT workup and, importantly, action before the labs resolve the question. Confirmation comes from an immunoassay (PF4 antibody, often reported as an optical density) and, when needed, a functional assay such as the serotonin release assay.

Stop ALL heparin — and be literal about it

When HIT is suspected, every source of heparin comes off. This is more thorough than it sounds, and the nurse is the one who finds the hidden sources:

• The therapeutic heparin drip and any prophylactic subcutaneous heparin.
• Line and arterial flushes that contain heparin — switch to saline.
• Heparin-coated (bonded) catheters and PA catheters — these keep exposing the patient.
• Heparin in dialysis or CRRT circuits and in TPN.

Low-molecular-weight heparin (enoxaparin) is not a safe substitute — it cross-reacts. Stopping heparin alone is also not enough, because the prothrombotic state persists for days.

Start a non-heparin anticoagulant

Two "never yet" rules matter at the bedside:

• Do not transfuse platelets just because the count is low. In HIT the patient is clotting, not bleeding, and pouring in platelets can add fuel. Transfusion is reserved for actual serious bleeding.
• Do not start warfarin until the platelet count has substantially recovered. Warfarin early in HIT can cause venous limb gangrene and skin necrosis by dropping protein C before the thrombin driver is controlled. Overlap warfarin only later, on top of a working non-heparin anticoagulant.

What the nurse watches for

Beyond the platelet trend, HIT announces itself through clotting complications and reactions: a newly swollen or painful limb, a cold pulseless extremity, chest pain or hypoxia (PE), stroke signs, a clotted dialysis circuit or arterial line, skin necrosis at heparin injection sites, and acute systemic symptoms (fever, chills, shortness of breath, hypertension) minutes after a heparin bolus. Any of these in a patient on heparin should raise HIT immediately. Documenting the platelet trend against the heparin start date, and flagging the pattern, is often what prompts the 4Ts calculation in the first place.

HIT vs. the other ICU thrombocytopenias

The ICU is full of low platelet counts — sepsis, medications, dilution, and DIC all cause them. Two contrasts anchor HIT: unlike DIC, HIT usually leaves the PT, PTT, and fibrinogen normal (the cascade isn't being consumed); and unlike most thrombocytopenias, HIT causes clots rather than bleeding. The timing (day 5–10) and the clotting picture together are what separate it from the crowd.

Bottom line

HIT flips the usual meaning of a low platelet count: the danger is clotting, not bleeding. Think of it when the count falls 5–10 days into heparin, score the 4Ts, and when suspicion is real, stop every source of heparin — flushes and coated lines included — and switch to a non-heparin anticoagulant, while withholding platelet transfusions and early warfarin. The bedside nurse who connects the dropping count to the heparin start date, and who resists the instinct to treat it as fragility, is the one who prevents the next clot.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.